Application of Digital Infrared Thermal Imaging (DITI) in Graves' Disease

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.

Verified December 2010 by National Taiwan University Hospital.
Recruitment status was: Recruiting

Sponsor:

Information provided by:

National Taiwan University Hospital

ClinicalTrials.gov Identifier:

NCT01182584

First received: August 12, 2010

Last updated: December 21, 2010

Last verified: December 2010

History of Changes

Purpose

Graves' disease is characterized by thyrotoxicosis, goiter, ophthalmopathy and dermopathy. Pathogenesis involves autoimmune process. The investigators think temperatures of the area involved in the inflammation may change. Thus the investigators plan to take temperature pictures of Graves' patients using digital infrared thermal imaging system and observe the change.

Condition
Graves' Disease


Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Prospective
Official Title:	Application of Digital Infrared Thermal Imaging in Thyroid Disease and Associated Ophthalmopathy and Dermopathy

Resource links provided by NLM:

Genetics Home Reference related topics: Graves disease

Genetic and Rare Diseases Information Center resources: Graves' Disease

U.S. FDA Resources

Further study details as provided by National Taiwan University Hospital:


Estimated Enrollment:	200
Study Start Date:	December 2009
Estimated Study Completion Date:	December 2011
Estimated Primary Completion Date:	October 2011 (Final data collection date for primary outcome measure)

Groups/Cohorts
Graves' disease
Healthy volunteers

Detailed Description:

We will recruited patients of Graves' disease from out patient clinics. We will perform thyroid echo and soft tissue echo first. Then we let patients sit before the thermal camera and take thermal images of eyes necks and tibia. After data collection, we analyse the relation between temperature and laboratory data such as thyroid function and autoimmune profiles.

Eligibility


Ages Eligible for Study:	16 Years to 60 Years (Child, Adult)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

Graves' disease patients with or without ophthalmopathy and dermopathy

Criteria

Inclusion Criteria:

Graves' disease patients. Healthy people

Exclusion Criteria:

Pregnancy. <16 years old or > 60 years old

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01182584

Contacts


Contact: Shyang-Rong Shih, M.D.	0972653337	srshih@ntu.edu.tw

Locations


Taiwan
National Taiwan University	Recruiting
Taipei, Taiwan
Contact: Shyang-Rong Shih, M.D. 0972653337 srshih@ntu.edu.tw

Sponsors and Collaborators

National Taiwan University Hospital

Investigators


Principal Investigator:	Shyang-Rong Shih	National Taiwan University

More Information


Responsible Party:	National Taiwan university
ClinicalTrials.gov Identifier:	NCT01182584 History of Changes
Other Study ID Numbers:	200811040R
Study First Received:	August 12, 2010
Last Updated:	December 21, 2010

Additional relevant MeSH terms:


Graves Disease Exophthalmos Orbital Diseases Eye Diseases Goiter	Thyroid Diseases Endocrine System Diseases Hyperthyroidism Autoimmune Diseases Immune System Diseases

ClinicalTrials.gov processed this record on June 26, 2017

To Top